Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

EQ Equillium Inc

1,43

-0,08 (-5,30%)

22 Mai 2024 - Fermé

Retardé de 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
d422930dars.pdf

Equillium (NASDAQ:EQ)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024

Plus de graphiques de la Bourse Equillium

Equillium (NASDAQ:EQ)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024

Plus de graphiques de la Bourse Equillium

Actualités Equillium, Inc.

Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
Mardi 14 Mai 2024 ( il y a 1 semaine) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jeudi 9 Mai 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
Jeudi 9 Mai 2024 ( il y a 2 semaines) • Business Wire

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
Mardi 7 Mai 2024 ( il y a 2 semaines) • Business Wire

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mercredi 3 Avril 2024 ( il y a 2 mois) • Business Wire

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
Lundi 1 Avril 2024 ( il y a 2 mois) • Business Wire

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
Lundi 25 Mars 2024 ( il y a 2 mois) • Business Wire

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
Vendredi 22 Mars 2024 ( il y a 2 mois) • Business Wire

Form 3 - Initial statement of beneficial ownership of securities
Vendredi 8 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 8 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 23 Février 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Vendredi 23 Février 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Plus d'articles sur Equillium, Inc.

NLBNPIT20YE3 20241220 40

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales